Snapshot from Jul 07, 2026 at 01:18 UTC. For live data and tracking: View Live
Entities / People / Zayn Malik
Person

Zayn Malik

Tracked across 1 events · 9 articles · First seen Dec 01, 2025 · Last active Jun 01, 2026

Sentiment
70
Attention
4
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (1)
4 70
Business
USFDA Accepts Wockhardt's Zaynich NDA
Impact: Zayn Malik is a novel, first-in-class antibiotic developed by Wockhardt, which has received fast-track designation and priority review from the United States — Food and Drug Administration for its potential to combat multi-drug resistant Gram-negative pathogens.
Dec 01, 2025 · 9 articles
ERGEN INTELLIGENCE
Track Zayn Malik live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.